Literature DB >> 28527406

The relevance of Ki calculation for bi-substrate enzymes illustrated by kinetic evaluation of a novel lysine (K) acetyltransferase 8 inhibitor.

Hannah Wapenaar1, Thea van den Bosch1, Niek G J Leus1, Petra E van der Wouden1, Nikolaos Eleftheriadis1, Jos Hermans2, Gebremedhin Solomon Hailu3, Dante Rotili3, Antonello Mai3, Alexander Dömling4, Rainer Bischoff2, Hidde J Haisma1, Frank J Dekker5.   

Abstract

Histone acetyltransferases (HATs) are important mediators of epigenetic post-translational modifications of histones that play important roles in health and disease. A disturbance of these modifications can result in disease states, such as cancer or inflammatory diseases. Inhibitors of HATs (HATi) such as lysine (K) acetyltransferase 8 (KAT8), could be used to study the epigenetic processes in diseases related to these enzymes or to investigate HATs as therapeutic targets. However, the development of HATi is challenged by the difficulties in kinetic characterization of HAT enzymes and their inhibitors to enable calculation of a reproducible inhibitory potency. In this study, a fragment screening approach was used, enabling identification of 4-amino-1-naphthol, which potently inhibited KAT8. The inhibitor was investigated for enzyme inhibition using kinetic and calorimetric binding studies. This allowed for calculation of the Ki values for both the free enzyme as well as the acetylated intermediate. Importantly, it revealed a striking difference in binding affinity between the acetylated enzyme and the free enzyme, which could not be revealed by the IC50 value. This shows that kinetic characterization of inhibitors and calculation of Ki values is crucial for determining the binding constants of HAT inhibitors. We anticipate that more comprehensive characterization of enzyme inhibition, as described here, is needed to advance the field of HAT inhibitors.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Enzyme kinetics; Fragment screening; Histone acetylation; Histone acetyltransferases; Inhibitor; KAT8

Mesh:

Substances:

Year:  2017        PMID: 28527406      PMCID: PMC5720340          DOI: 10.1016/j.ejmech.2017.05.015

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  22 in total

1.  The language of covalent histone modifications.

Authors:  B D Strahl; C D Allis
Journal:  Nature       Date:  2000-01-06       Impact factor: 49.962

Review 2.  Structure and function of histone acetyltransferases.

Authors:  R Marmorstein
Journal:  Cell Mol Life Sci       Date:  2001-05       Impact factor: 9.261

3.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

Review 4.  Aberrant lysine acetylation in tumorigenesis: Implications in the development of therapeutics.

Authors:  Stephanie Kaypee; Deepthi Sudarshan; Muthu K Shanmugam; Debanjan Mukherjee; Gautam Sethi; Tapas K Kundu
Journal:  Pharmacol Ther       Date:  2016-01-22       Impact factor: 12.310

5.  Observations on screening-based research and some concerning trends in the literature.

Authors:  Jonathan B Baell
Journal:  Future Med Chem       Date:  2010-10       Impact factor: 3.808

6.  A human protein complex homologous to the Drosophila MSL complex is responsible for the majority of histone H4 acetylation at lysine 16.

Authors:  Edwin R Smith; Christelle Cayrou; Rong Huang; William S Lane; Jacques Côté; John C Lucchesi
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

7.  Subunit composition and substrate specificity of a MOF-containing histone acetyltransferase distinct from the male-specific lethal (MSL) complex.

Authors:  Yong Cai; Jingji Jin; Selene K Swanson; Michael D Cole; Seung Hyuk Choi; Laurence Florens; Michael P Washburn; Joan W Conaway; Ronald C Conaway
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

8.  Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS.

Authors:  Stephen J Capuzzi; Eugene N Muratov; Alexander Tropsha
Journal:  J Chem Inf Model       Date:  2017-02-25       Impact factor: 4.956

9.  Enzyme kinetics and inhibition of histone acetyltransferase KAT8.

Authors:  Hannah Wapenaar; Petra E van der Wouden; Matthew R Groves; Dante Rotili; Antonello Mai; Frank J Dekker
Journal:  Eur J Med Chem       Date:  2015-10-22       Impact factor: 6.514

10.  PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS.

Authors:  Jayme L Dahlin; J Willem M Nissink; Jessica M Strasser; Subhashree Francis; LeeAnn Higgins; Hui Zhou; Zhiguo Zhang; Michael A Walters
Journal:  J Med Chem       Date:  2015-02-21       Impact factor: 8.039

View more
  2 in total

Review 1.  The Process and Strategy for Developing Selective Histone Deacetylase 3 Inhibitors.

Authors:  Fangyuan Cao; Martijn R H Zwinderman; Frank J Dekker
Journal:  Molecules       Date:  2018-03-02       Impact factor: 4.411

2.  Comparison of Constituents and Antioxidant Activity of Above-Ground and Underground Parts of Dryopteris crassirhizoma Nakai Based on HS-SPME-GC-MS and UPLC/Q-TOF-MS.

Authors:  Yanjia Wang; Baodong Liu; Xin Wang; Yawen Fan
Journal:  Molecules       Date:  2022-08-05       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.